Fei Yan
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 0.5%
- Nanoplatforms for cancer theranostics
- Ultrasound and Hyperthermia Applications
- Photoacoustic and Ultrasonic Imaging
Papers in
-
- Ultrasound and Hyperthermia Applications 67
- Photoacoustic and Ultrasonic Imaging 45
- Nanoplatforms for cancer theranostics 43
- Microfluidic and Bio-sensing Technologies 8
-
- RNA Interference and Gene Delivery 12
- Co-authors
- Hairong Zheng (48 shared papers)Zhiting Deng (21 shared papers)Hairong Zheng (11 shared papers)Junru Wu (12 shared papers)Qiaofeng Jin (13 shared papers)Hongmei Liu (10 shared papers)Xin Liu (4 shared papers)Wanlu Duan (4 shared papers)
- Journals
- Theranostics (11 papers)International Journal of Nanomedicine (7 papers)Ultrasound in Medicine & Biology (7 papers)Pharmaceutics (6 papers)PLoS ONE (6 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Fei Yan
188 papers receiving 5.6k citations
Fei Yan's Hit Papers
Peers
Comparison fields: 5 of 139
- Biomaterials 1.3k
- Biomedical Engineering 3.3k
- Pharmaceutical Science 201
- Biotechnology 278
- Molecular Medicine 107
Countries citing papers authored by Fei Yan
This map shows the geographic impact of Fei Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Yan more than expected).
Fields of papers citing papers by Fei Yan
This network shows the impact of papers produced by Fei Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Yan. The network helps show where Fei Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 198 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 220 | |
| 2 | 2018 | 213 | |
| 3 | 2013 | 206 | |
| 4 | 2009 | 201 | |
| 5 | 2018 | 147 | |
| 6 | 2016 | 136 | |
| 7 | Spatiotemporal control of engineered bacteria to express interferon-γ by focused ultrasound for tumor immunotherapy Hit paper breakdown → | 2022 | 135 |
| 8 | 2019 | 119 | |
| 9 | 2018 | 110 | |
| 10 | 2017 | 108 | |
| 11 | 2022 | 108 | |
| 12 | 2016 | 107 | |
| 13 | 2016 | 97 | |
| 14 | 2010 | 91 | |
| 15 | 2018 | 85 | |
| 16 | 2017 | 83 | |
| 17 | 2018 | 82 | |
| 18 | 2014 | 79 | |
| 19 | 2018 | 78 | |
| 20 | 2023 | 77 |
About Fei Yan
Fei Yan is a scholar working on Biomedical Engineering, Molecular Biology, Biomaterials, Materials Chemistry and Surgery, having authored 198 papers that have together received 5.6k indexed citations. Recurring topics across this work include Ultrasound and Hyperthermia Applications (67 papers), Photoacoustic and Ultrasonic Imaging (45 papers), Nanoplatforms for cancer theranostics (43 papers), Nanoparticle-Based Drug Delivery (26 papers), Ultrasound and Cavitation Phenomena (14 papers), RNA Interference and Gene Delivery (12 papers), Cancer Research and Treatments (9 papers) and Microfluidic and Bio-sensing Technologies (8 papers). The work is most often cited by research in Biomaterials (1.3k citations), Biomedical Engineering (3.3k citations), Pharmaceutical Science (201 citations), Biotechnology (278 citations) and Molecular Medicine (107 citations). Fei Yan has collaborated with scholars based in China, United States and France. Frequent co-authors include Hairong Zheng, Zhiting Deng, Hairong Zheng, Junru Wu, Qiaofeng Jin, Hongmei Liu, Xin Liu, Wanlu Duan, Hao Wu and Zonghai Sheng. Their work appears in journals such as Theranostics, International Journal of Nanomedicine, Ultrasound in Medicine & Biology, Pharmaceutics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.